Sartorius Stedim Biotech Aktie
162,80
EUR
-3,80
EUR
-2,28
%
163,40
EUR
-0,80
EUR
-0,49
%
Sartorius Stedim Biotech jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Sartorius Stedim Biotech Aktie Analyse
| 17.10.24 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 03.10.24 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
| 03.10.24 | Sartorius Stedim Biotech Neutral | UBS AG | |
| 02.09.24 | Sartorius Stedim Biotech Outperform | RBC Capital Markets | |
| 29.07.24 | Sartorius Stedim Biotech Underperform | Bernstein Research | |
| 27.06.24 | Sartorius Stedim Biotech Equal Weight | Barclays Capital | |
| 23.04.24 | Sartorius Stedim Biotech Equal Weight | Barclays Capital | |
| 12.03.24 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 29.09.23 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
| 06.09.23 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
| 11.08.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group | |
| 20.06.23 | Sartorius Stedim Biotech Buy | UBS AG | |
| 19.06.23 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 18.04.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group | |
| 07.03.23 | Sartorius Stedim Biotech Buy | HSBC | |
| 22.07.22 | Sartorius Stedim Biotech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.07.22 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 04.07.22 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 22.04.22 | Sartorius Stedim Biotech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.01.21 | Sartorius Stedim Biotech overweight | JP Morgan Chase & Co. | |
Werbung
Werbung